Vaccinal Prevention of the Diseases Caused by Human Papillomavirus: Evidence-Based Medicine. Review of Clinical Guidelines

Cervical cancer (CC) occupies the fifth place in the structure of female oncopathology (n Russia. The share of CC is 5.2 % among all oncological diseases. iin Russia, 6.392 women died of CC in 2018. And the mortality rate from this disease is growing every year. In recent years, there has been an increase in the mortality rate among women aged 35 to 59 years at the age of the greatest social activity. The problem of etiology, pathogenesis and diagnosis of the disease remains relevant, despite the active development of medical science. The main cause of CC is considered to be the human papillomavirus of oncogenic genotypes. At the same time, even the active introduction of vaccination does not lead to a decrease in the rate of increase in morbidity and mortality from CC. At the same time, it is known that risk factors for the occurrence of the disease are early onset of sexual activity, frequent change of sexual partners, rejection of barrier methods of contraception, smoking, immunosuppression. Currently, the issue of the influence of sexually transmitted infections on the occurrence of CC has not been fully studied. We wondered what etiological factors have been most studied and reliably influence the occurrence of the disease, what preventive measures can help in this. We assume that only an integrated approach (lifestyle changes, vaccination, preventive medical examinations) can help defeat CC. The article discusses the key causes of the disease, the history of the study of the etiology of CC, the current state of the problem.

show abstract

General principles of vaccination of patients with neuromuscular diseases

Skorikov,

Vlodavets

2023

Neuromuscular Diseases

View full text Add to dashboard Cite

Vaccination is recognized as the most effective, safe, and cost-effective way to prevent infectious diseases and their complications. For patients with chronic diseases, and for patients with neuromuscular diseases in particular, vaccination is the highest priority for the prevention of infectious diseases. In the current literature, there is a lack of information describing the principles of vaccination of patients with spinal muscular atrophy and Duchenne muscular dystrophy. In patients with neuromuscular diseases, full immunization has to be done in accordance with the National calendar and recommendations with the introduction of an additional vaccine against such diseases as: rotavirus infection, pneumococcal infection (using an additional dose of 23-valent vaccine), meningococcal infection, virus human papilloma, respiratory viral infection. syncytial virus and influenza. In this regard, of particular importance is the development of recommendations describing the schemes for the use of vaccines in children suffering from spinal muscular atrophy and Duchenne muscular dystrophy.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Vaccinal Prevention of the Diseases Caused by Human Papillomavirus: Evidence-Based Medicine. Review of Clinical Guidelines

Cited by 11 publications

References 35 publications

Vaccination of HIV-infected patients during pregnancy planning

Vaccination of HIV-infected patients during pregnancy planning

Topical aspects of etiology and prevention of cervical cancer

General principles of vaccination of patients with neuromuscular diseases

Contact Info

Product

Resources

About